alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000814576
<NAME> PAINEWEBBER R&D PARTNERS II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                           4,975       
<SECURITIES>                                 2,565,763
<RECEIVABLES>                                   16,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,586,738
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               2,747,128
<CURRENT-LIABILITIES>                           73,585
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   2,673,543
<TOTAL-LIABILITY-AND-EQUITY>                 2,747,128
<SALES>                                              0
<TOTAL-REVENUES>                              (541,455)
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               287,217
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (828,672)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (828,672)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7507 Enrolled Bill (ENR)]

        H.R.7507

                     One Hundred Eighteenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

         Begun and held at the City of Washington on Wednesday,
         the third day of January, two thousand and twenty-four

                                 An Act

 
To designate the facility of the United States Postal Service located at 
203 East 6th Street in Lexington, Nebraska, as the `William E. and Elsie 
                    L. Barrett Post Office Building.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. WILLIAM E. AND ELSIE L. BARRETT POST OFFICE BUILDING.
    (a) Designation.--The facility of the United States Postal Service 
located at 203 East 6th Street in Lexington, Nebraska, shall be known 
and designated as the ``William E. and Elsie L. Barrett Post Office 
Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``William E. 
and Elsie L. Barrett Post Office Building''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
AXS-One, Inc.:

We consent to the incorporation by reference in the Registration Statements (Nos. 333-11681, 333-49733, 333-61125, 333-72142, 333-72138, 333-119327 and 333-126554) on Form S-8 and (Nos. 333-144559, 333-49731, 333-115145, 333-126555, and 333-129149) on Form S-3 of AXS-One, Inc. and Subsidiaries of our report dated April 11, 2008, with respect to the consolidated financial statements and the related financial statement schedule as of December 31, 2007 and 2006 and for the years then ended, which appears in the December 31, 2007 annual report on Form 10-K of AXS-One, Inc. and Subsidiaries.

The following explanatory paragraph was included in our report dated April 11, 2008: The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered losses from operations and incurred a working capital deficiency. These facts, among others, raise substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters also are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

/s/ Amper, Politziner & Mattia, PC

April 11, 2008
Edison, New Jersey

---
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3946 Dengue virus nucleic acid amplification test reagents. ( a ) *Identification.* Dengue virus nucleic acid amplification test reagents are devices that consist of primers, probes, enzymes, and controls for the amplification and detection of dengue virus serotypes 1, 2, 3, or 4 from viral ribonucleic acid (RNA) in human serum and plasma from individuals who have signs and symptoms consistent with dengue (mild or severe). The identification of dengue virus serotypes 1, 2, 3, or 4 in human serum and plasma (sodium citrate) collected from human patients with dengue provides epidemiologic information for surveillance of circulating dengue viruses.
( b ) *Classification.* Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Dengue Virus Nucleic Acid Amplification Test Reagents.” For availability of the guideline document, see § 866.1(e).
[79 FR 53609, Sept. 10, 2014]
================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1933

                                  May 13, 2003
         --------------------------------------------------------------
                Date of Report (date of earliest event reported)

                              APPLIED IMAGING CORP.
--------------------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)

        Delaware                    0-21371                      77-0120490
--------------------------------------------------------------------------------
    (State or other         (Commission File Number)          (I.R.S. Employer
    jurisdiction of                                            Identification
    incorporation or                                              Number)
     organization)
                               2380 Walsh Avenue,
                                   Building B,
                             Santa Clara, California
         --------------------------------------------------------------
                    (Address of principal executive offices)

                                 (408) 562-0250
         --------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
          (Former name or former address, if changed since last report)

================================================================================


<PAGE>

ITEM 5. OTHER EVENTS

      On May 13, 2003, Applied Imaging Corp. issued a press release announcing
its earnings for the first quarter of fiscal 2003. A copy of the press release
is attached hereto as Exhibit 99.1.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

      (c) Exhibits. The following exhibits are filed with this report.

Exhibit Number                           Description
--------------        -------------------------------------------------
    99.1              Press Release dated May 13, 2003


<PAGE>

      Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                       APPLIED IMAGING CORP.

                                       By:  /s/ Carl Hull
                                            ------------------------------------
                                            Carl Hull
                                            President & Chief Executive Officer

      Dated: May 13, 2003
# C_2015311EN.01006102.xml

| 21.9.2015 | EN | Official Journal of the European Union | C 311/61 |
| --- | --- | --- | --- |

21.9.2015

EN

Official Journal of the European Union

C 311/61

---

Order of the General Court of 29 June 2015 — PSL v OHIM — Consortium Ménager Parisien (Representation of a watch)

(Case T-212/14) (1)

1

(2015/C 311/68)

Language of the case: English

The President of the Fourth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 245, 28.7.2014.

1

---
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA F OURTH D ISTRICT

JOSEPH JAMAL WALKER , Appellant,

v.

STATE OF FLORIDA , Appellee

.

No s . 4D 16

- 3994, 4D16

- 4161 and 4D16

- 4253

[ May 16, 2018 ]

Consolidated a ppeal s from the Circuit Court for the Fifteenth Judicial Circuit, Palm Beach County ; Krista Marx , Judge; L.T. Case No s

. 50

- 2010

- CF

- 014607B, 50

- 2011

- CF

- 000626A and 50

- 2014

- CF002429A

.
Carey Haughwout, Public Defender, and J. Woodson Isom, Assistant Public Defender, West Palm Beach, for appellant.

Pamela Jo Bondi, Attorney General, Tallahassee, and Ilana Mitzner, Assistant Attorney General, West Palm Beach, for appellee.

P ER C URIAM

.
We affirm the convictions and sentences in all respects. We remand to the circuit court for correction of the written re vocation order to conform to the court’s oral pronouncement. The written order contains a violation for failing to undergo a drug and alcohol evaluation; in its oral pronouncement, the court ruled that violation had not been established. The written orde r also contains a violation for committing the offense of possession of a firearm by a convicted felon; however, the s tate nolle prossed that count at sentencing after the court’s oral pronouncement.

Affirmed and remanded for correction

.

W ARNER , G ROSS and L EVINE , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
I 

118TH CONGRESS 

2D SESSION H. R. 7697 

To amend title XVI of the Social Security Act to apply cost-of-living adjustments to the minimum monthly personal needs allowance for institutionalized individuals and couples under the supplemental security income 

program, and require State supplementary payments under that program 

to be increased by the amount of each such adjustment. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 15, 2024 

Mr. KILDEE (for himself and Mr. CAREY) introduced the following bill; which 

was referred to the Committee on Ways and Means 

A BILL 

To amend title XVI of the Social Security Act to apply 

cost-of-living adjustments to the minimum monthly personal needs allowance for institutionalized individuals 

and couples under the supplemental security income program, and require State supplementary payments under 

that program to be increased by the amount of each 

such adjustment. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7697 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Dignity and Autonomy 

3 for Our Supplemental Security Income PNA Beneficiaries 

4 Act’’. 

5 SEC. 2. APPLICATION OF COST-OF-LIVING ADJUSTMENTS 

6 TO THE PERSONAL NEEDS ALLOWANCE; 

7 PASS-THROUGH TO STATE SUPPLEMENTARY 

8 PAYMENTS. 

9 (a) APPLICATION OF COST-OF-LIVING ADJUSTMENTS

10 TO THE PERSONAL NEEDS ALLOWANCE.— 

11 (1) IN GENERAL.—Section 1617(a)(1) of the 

12 Social Security Act (42 U.S.C. 1382f(a)(1)) is 

13 amended by striking ‘‘and (b)(2)’’ and inserting 

14 ‘‘(b)(2), and (e)(1)(B)’’. 

15 (2) CONFORMING AMENDMENTS.—Section 

16 1611(e)(1)(B) of such Act (42 U.S.C. 

17 1382(e)(1)(B)) is amended in each of clauses (i) 

18 through (iii) by inserting ‘‘(or, if greater, the 

19 amount determined under section 1617)’’ after each 

20 dollar amount specified in such clauses. 

21 (3) APPLICABILITY.—The amendments made 

22 by this subsection shall apply with respect to benefit 

23 amount increases for months after September 30, 

24 2024. 

25 (b) PASS-THROUGH TO STATE SUPPLEMENTARY

26 PAYMENTS.— 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7697 IH

1 (1) IN GENERAL.—Section 1618(g) of the So2 cial Security Act (42 U.S.C. 1382g(g)) is amend3 ed— 

4 (A) by striking ‘‘1987’’ each place it ap5 pears and inserting ‘‘2024’’; and 

6 (B) in paragraph (4)(B), by striking ‘‘in7 creased—’’ and all that follows and inserting 

8 ‘‘increased by the amount of all cost-of-living 

9 adjustments under section 1617 to benefits de10 termined under section 1611(e)(1)(B) which 

11 have occurred after September 2024 and before 

12 that particular month.’’. 

13 (2) EFFECTIVE DATE.—The amendments made 

14 by paragraph (1) shall take effect on October 1, 

15 2024. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-START>                             DEC-26-1999
<PERIOD-END>                               SEP-23-2000
<CASH>                                           2,779
<SECURITIES>                                         0
<RECEIVABLES>                                   67,133
<ALLOWANCES>                                    10,255
<INVENTORY>                                     32,372
<CURRENT-ASSETS>                                98,024
<PP&E>                                         109,807
<DEPRECIATION>                                  41,348
<TOTAL-ASSETS>                                 342,283
<CURRENT-LIABILITIES>                           62,252
<BONDS>                                        222,486
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            81
<OTHER-SE>                                      54,459
<TOTAL-LIABILITY-AND-EQUITY>                   342,283
<SALES>                                        222,565
<TOTAL-REVENUES>                               222,565
<CGS>                                          164,607
<TOTAL-COSTS>                                  164,607
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,370
<INCOME-PRETAX>                                (4,051)
<INCOME-TAX>                                   (1,698)
<INCOME-CONTINUING>                            (2,353)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,353)
<EPS-BASIC>                                     (0.32)
<EPS-DILUTED>                                   (0.32)


</TABLE>
§ 830.10 Incorporation by reference. ( a ) Certain material is incorporated by reference into this part with the approval of the Director of the Federal Register in accordance with 5 U.S.C. 552(a) and 1 CFR part 51. To enforce any edition other than that specified in this section, the Food and Drug Administration must publish notice of change in the Federal Register and the material must be available to the public. All approved material is available for inspection at the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, 301-827-6860, and is available from the source listed in paragraph (b) of this section. Copies are also available for purchase from the American National Standards Institute (ANSI), mailing address: ANSI, Attn: Customer Service Department, 25 West 43rd St., 4th floor, New York, NY 10036, phone: 212-642-4980, and may be ordered online at *http://webstore.ansi.org/ .* The material is also available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030 or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( b ) International Organization for Standardization (ISO), mailing address: ISO, Attn: ISO Central Secretariat, 1, ch. de la Voie-Creuse, Case postale 56, CH-1211 Geneva 20, Switzerland, phone (dialing from the United States): 011-41-22-749-0111, and may be ordered online at *http://www.standardsinfo.net .* ( 1 ) ISO/IEC 646:1991(E), Information technology—ISO 7-bit coded character set for information interchange (third edition; December 15, 1991), into §§ 830.20(c) and 830.100(b);
( 2 ) ISO/IEC 15459-2:2006(E), Information technology—Unique identifiers—Part 2: Registration procedures (second edition; March 1, 2006), into §§ 830.20(b) and 830.100(b);
( 3 ) ISO/IEC 15459-4:2008(E), Information technology—Unique identifiers—Part 4: Individual items (second edition; July 15, 2008), into §§ 830.20(b) and 830.100(b);
( 4 ) ISO/IEC 15459-6:2007(E), Information technology—Unique identifiers—Part 6: Unique identifier for product groupings (first edition; June 15, 2007), into §§ 830.20(b) and 830.100(b).
[78 FR 58823, Sept. 24, 2013, as amended at 88 FR 45067, July 14, 2023]
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5630 *Beta*-2-microglobulin immunological test system. ( a ) *Identification.* A *beta*-2-microglobulin immunological test system is a device that consists of the reagents used to measure by immunochemical techniques *beta*-2-microglobulin (a protein molecule) in serum, urine, and other body fluids. Measurement of *beta*-2-microglobulin aids in the diagnosis of active rheumatoid arthritis and kidney disease.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 84 FR 71800, Dec. 30, 2019]
Exhibit 32



Certifications Pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350)



The undersigned, as the President and Chief Executive Officer, and Executive
Vice President and Chief Financial Officer of Exide Technologies, each certify that



(1) the accompanying Quarterly Report on Form 10-Q for the period ended December 31, 2004, fully complies with the requirements of Section
13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and



(2) the information contained in the periodic report fairly presents, in all material respects, the financial condition and results of
operations of Exide Technologies at the dates and for the periods indicated.



The foregoing certification is made pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350) and no purchaser or seller of securities or any other person shall be entitled to rely upon the
foregoing certification for any other purpose.



A signed
original of this written statement required by Section 906 has been provided to Exide Technologies and will be retained by Exide Technologies and furnished to the Securities and Exchange Commission or its staff upon request.



The undersigned expressly disclaims any obligation to update the foregoing
certification except as required by law.



Date: February 14, 2005



/S/    CRAIG H.
MUHLHAUSERCraig H. MuhlhauserPresident and Chief Executive Officer




/s/    J. TIMOTHY
GARGAROJ. Timothy GargaroExecutive Vice President and Chief Financial Officer
<PAGE>   1

                                                                    EXHIBIT 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS



We consent to the inclusion in the 1997 Annual Report on Form 10-K of Harbinger
Corporation and to the incorporation by reference in the registration statements
of Harbinger Corporation on Form S-3 (File Nos. 33-96774, 333-03247, 333-30219
and 333-42959) of our report dated January 31, 1997, except for Paragraph 3 of
Note 16 as to which the date is March 16, 1997, on our audits of the
consolidated financial statements and financial statement schedule of Premenos
Technology Corp. and subsidiaries as of December 31, 1996, and for each of the
two years in the period then ended, which report is included in the Premenos
Technology Corp. 1996 Annual Report on Form 10-K.




                                             COOPERS & LYBRAND L.L.P.


San Francisco, California
March 25, 1998







                                       79
**Exhibit
      32(b)**





**Certification
      of Chief Financial Officer Pursuant to 18 U.S.C. § 1350**


**(Section
      906 of the Sarbanes-Oxley Act of 2002)**





Pursuant
      to 18 U.S.C. § 1350, the undersigned officer of Republic Bancorp Inc. (the
“Company”) hereby certifies, to such officer’s knowledge, that the Company’s
      Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2006
      (the
“Report”) fully complies with the requirements of Section 13(a) or 15(d), as
      applicable, of the Securities Exchange Act of 1934 and that the information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company.








Date:
                August 7, 2006
            /s/
                Thomas F. MenacherName:
                Thomas F. MenacherTitle:
                Executive Vice President, Treasurer and Chief Financial
                Officer





The
      foregoing certification (i) accompanies the filing and is being furnished solely
      pursuant to 18 U.S.C. § 1350, (ii) will not be deemed “filed” for purposes of
      Section 18 of the Securities Exchange Act of 1934, or otherwise subject to
      the
      liability of that section, and (iii) will not be deemed to be incorporated
      by
      reference into any filing under the Securities Act of 1933 or the Exchange
      Act,
      except to the extent that the registrant specifically incorporates it by
      reference.








A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Republic Bancorp Inc. and will be retained
      by Republic Bancorp Inc. and furnished to the Securities and Exchange Commission
      or its staff upon request.